Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Interest Paid, Including Capitalized Interest, Operating and Investing Activities

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Interest Paid, Including Capitalized Interest, Operating and Investing Activities

AIM IMMUNOTECH INC. (AIM) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of -$3.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-31.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:InterestPaid · last filed 2017-03-31

  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-12-31 was -$6.00K.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-09-30 was $1.00K.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-06-30 was $0.00.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2015-03-31 was $2.00K, a 33.33% decline year-over-year.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was -$3.00K.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was -$11.00K, a 168.75% decline from fiscal 2013.
  • AIM IMMUNOTECH INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $16.00K.
Period endInterest Paid, Including Capitalized Interest, Operating and Investing Activities 3 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 6 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month as first filedInterest Paid, Including Capitalized Interest, Operating and Investing Activities 9 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month as first filedInterest Paid, Including Capitalized Interest, Operating and Investing Activities 12 monthInterest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month as first filed
2015-12-31-$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$5.00K
derived: sum of 2 quarters · filed 2017-03-31
-$5.00K
derived: sum of 3 quarters · filed 2017-03-31
-$3.00K
10-K · filed 2017-03-31
$3.00K
10-K · filed 2016-03-29
2015-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$1.00K
derived: sum of 2 quarters · filed 2016-11-14
$3.00K
10-Q · filed 2016-11-14
-$3.00K
10-Q · filed 2015-11-16
$1.00K
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$2.00K
10-Q · filed 2016-08-15
-$2.00K
10-Q · filed 2015-08-12
$0.00
derived: sum of 3 quarters · filed 2017-03-31
$0.00
derived: sum of 4 quarters · filed 2017-03-31
2015-03-31$2.00K
10-Q · filed 2016-05-16
$0.00
derived: sum of 2 quarters · filed 2017-03-31
$0.00
derived: sum of 3 quarters · filed 2017-03-31
-$12.00K
derived: sum of 4 quarters · filed 2017-03-31
2014-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$2.00K
derived: sum of 2 quarters · filed 2017-03-31
-$14.00K
derived: sum of 3 quarters · filed 2017-03-31
-$11.00K
10-K · filed 2017-03-31
$11.00K
10-K · filed 2016-03-29
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
-$12.00K
derived: sum of 2 quarters · filed 2015-11-16
-$9.00K
10-Q · filed 2015-11-16
$151.00K
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30-$12.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
-$9.00K
10-Q · filed 2015-08-12
$151.00K
derived: sum of 3 quarters · filed 2016-03-29
$105.00K
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31$3.00K
10-Q · filed 2015-05-12
$163.00K
derived: sum of 2 quarters · filed 2016-03-29
$117.00K
derived: sum of 3 quarters · filed 2016-03-29
2013-12-31$160.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$114.00K
derived: sum of 2 quarters · filed 2016-03-29
$16.00K
10-K · filed 2016-03-29
2013-09-30-$46.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$144.00K
10-Q · filed 2014-11-07
2013-06-30-$98.00K
10-Q · filed 2014-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B